This post is part of Japan: A Special Report for Investors.

"Japan's tsunami has struck worldwide," says Richard Moroney, the editor of Dow Theory Forecasts, which has maintained a model portfolio of blue chip stocks for over 50 years.

Here, he reviews a number of the top buy recommendations in the newsletter's portfolios to determine the potential risk posed by the recent tragic developments in Japan.

Stocks cited as "Focus List Buys" are are those issues that the service expect to significantly outperform the market over the next 12 months.

Continue reading Japan: Dow Theory's Blue Chip Portfolio Review

Japan: Dow Theory's Blue Chip Portfolio Review originally appeared on BloggingStocks on Wed, 23 Mar 2011 12:40:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Applied Materials (AMAT) to overweight from neutral at Piper Jaffray.
• Air Products (APD) to buy from hold at Citigroup.
• Youku.com (YOKU) and Pinnacle West (PNW) to buy from neutral at Goldman.
• Stryker (SYK) and Zimmer (ZMH) to buy from neutral at UBS.
• Zions Bancorp (ZION) to outperform from neutral at Macquarie.
• Alnylam (ALNY) to buy from hold at Needham.
• AK Steel (AKS) to buy from hold at KeyBanc.

Continue reading Analyst Calls: AEP, AKS, AMAT, EZCH, FRX, LOPE, MYGN, PNW, ZION ...

Analyst Calls: AEP, AKS, AMAT, EZCH, FRX, LOPE, MYGN, PNW, ZION ... originally appeared on BloggingStocks on Wed, 23 Feb 2011 11:40:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Ryder (R) to outperform from sector perform at RBC Capital.
• HCP (HCP) to outperform from neutral at RW Baird.
• Hertz Global (HTZ) to overweight from equal weight at Barclays.
• Lincoln National (LNC) to buy from neutral and T. Rowe Price (TROW) to conviction buy from neutral at Goldman.
• Protective Life (PL) and Janus Capital (JNS) to neutral from sell at Goldman.
• Newell Rubbermaid (NWL) to overweight from equal weight at Morgan Stanley.
• National Instruments (NATI) to overweight from neutral at JPMorgan.
• Team Health (TMH) to buy from hold at Deutsche Bank.

Continue reading Analyst Calls: BBT, BBY, EV, GDP, HTZ, JNS, LZB, NWL, R, TMK, TROW ...

Analyst Calls: BBT, BBY, EV, GDP, HTZ, JNS, LZB, NWL, R, TMK, TROW ... originally appeared on BloggingStocks on Wed, 15 Dec 2010 11:00:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• Citigroup upgraded Mosaic (MOS) to buy from hold and raised its price target to $78 from $64 citing improving ag fundamentals and the potential for BHP (BHP) to issue a higher bid for Potash (POT), which Citi feels would bode well for Mosaic.
• Cowen upgraded VMware (VMW) to outperform from neutral, citing recent share weakness and the company's significant growth opportunity.
• Citigroup upgraded CareFusion (CFN) with a $29 price target, citing valuation and the potential for margin expansion.
• Pfizer (PFE) was upgraded to outperform from neutral at Cowen.
• Juniper (JNPR) was upgraded to outperform from perform at Oppenheimer.
• Stryker (SYK) was upgraded to buy from gradually accumulate at Soleil.

Continue reading Analyst Calls: ALKS, AMLN, BAC, CFN, FWLT, MOS, PFE, VMW, WFR ...

Analyst Calls: ALKS, AMLN, BAC, CFN, FWLT, MOS, PFE, VMW, WFR ... originally appeared on BloggingStocks on Wed, 20 Oct 2010 12:00:00 EST. Please see our terms for use of feeds.

Analyst Upgrades

• JPMorgan upgraded AstraZeneca (AZN) to neutral from underweight after the company's U.S. Crestor patent was ruled valid. The firm believes the ruling could lead to AstraZeneca announcing a sizeable share buyback program. AstraZeneca was also upgraded to buy from neutral at BofA/Merrill and to hold from underperform at Jefferies.
• Deutsche Bank upgraded Peabody Energy (BTU) to buy from hold, citing valuation and attractive fundamentals in the coal sector. The firm has a $57.50 price target for shares, and also maintains buy ratings on Arch Coal (ACI) and Alpha Natural (ANR).
• Oppenheimer upgraded NextEra Energy (NEE) to outperform from perform, citing valuation and an improving regulation outlook in Florida. The firm maintains a $55 price target for shares.
• Eaton Vance (EV) was upgraded to buy from neutral at BofA/Merrill.
• Dynamex (DDMX) was upgraded to overweight from equal weight at Stephens.
• Soleil upgraded RPM (RPM) to buy from gradually accumulate.

Continue reading Analyst Calls: AZN, BTU, CSX, FTE, HCBK, NEE, NFLX, STJ, UNP ...

Analyst Calls: AZN, BTU, CSX, FTE, HCBK, NEE, NFLX, STJ, UNP ... originally appeared on BloggingStocks on Wed, 30 Jun 2010 12:15:00 EST. Please see our terms for use of feeds.

From TheStreet.com Network

• Ariad Upgraded, Xenoport Drug Delayed: BioBuzz
• Holiday Deals Heat Up at Big Retailers

Continue reading Cramer on BloggingStocks: Pelosi can't kill the health care sector

Cramer on BloggingStocks: Pelosi can't kill the health care sector originally appeared on BloggingStocks on Mon, 09 Nov 2009 10:10:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• FBR Capital upgraded M&T Bank (NYSE: MTB) to Market Perform from Underperform following the Q3 results to reflect the company's improved earnings outlook and better credit trends. The firm has a $70 price target on shares.
• Kaufman Bros. upgraded Autodesk (NASDAQ: ADSK) to Buy from Hold as it believes a bottom has been reached in the manufacturing and construction industries. The firm raised its target on shares to $30 from $26.
• Goldman upgraded Caterpillar (NYSE: CAT) to Neutral from Sell and raised its target to $64 from $48 citing improved cost controls and construction outlook.
• Pentair (NYSE: PNR) was upgraded to Buy from Hold at KeyBanc.
• Lexmark (NYSE: LXK) was upgraded to Neutral from Underweight at JPMorgan.
• Stryker (NYSE: SYK) was upgraded to Neutral from Underperform at BofA/Merrill.

Continue reading Analyst upgrades, downgrades and initiations: BCS, CAT, LMT, MTB, NVS, WSM ...

Analyst upgrades, downgrades and initiations: BCS, CAT, LMT, MTB, NVS, WSM ... originally appeared on BloggingStocks on Wed, 21 Oct 2009 11:30:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• Deutsche Bank upgraded Blackrock (NYSE: BLK) to Buy from Hold as it believes the BGI acquisition is becoming more accretive with the market rally and that the company's core trends are healthy. The firm raised its target on shares to $230 from $180.
• Citigroup upgraded Burlington Northern (NYSE: BNI) to Hold from Sell as it believes the risk/reward on shares is balanced based on 2010 estimates. Citi raised its target on shares to $89 from $75.
• Auriga upgraded Eclipsys (NASDAQ: ECLP) to Buy from Hold on expectations the company's margin expansion initiatives will drive benefits in 2010 and 2011. The firm raised its target on shares to $24 from $16.
• Seagate (NASDAQ: STX) was upgraded to Overweight from Market Weight at Thomas Weisel and to Buy from Hold at Deutsche Bank.
• Web.com (NASDAQ: WWWW) was upgraded to Outperform from Market Perform at FBR Capital.
• CenturyTel (NYSE: CTL) was upgraded to Overweight from Equal Weight at Morgan Stanley.

Continue reading Analyst upgrades, downgrades and initiations: AMZN, BLK, BNI, CCL, JPM, PNC, UTX ...

Analyst upgrades, downgrades and initiations: AMZN, BLK, BNI, CCL, JPM, PNC, UTX ... originally appeared on BloggingStocks on Wed, 23 Sep 2009 10:40:00 EST. Please see our terms for use of feeds.

Analyst upgrades:

• Citigroup upgraded Advanced Micro (NYSE: AMD) to Buy from Hold and raised its target to $5.50 from $4.25 citing valuation and expectations for the company's competitive position and gross margins to improve.
• Barclays upgraded American Express (NYSE: AXP) to Overweight from Equal Weight citing long-term earnings growth as the company benefits from declining charge-offs and credit costs. The firm has a $38 target on the stock.
• JPMorgan upgraded Arch Coal (NYSE: ACI) to Overweight from Neutral and raised its target to $22 from $19 citing the FTC approval for the acquisition of Jacobs Ranch mine and valuation.
• Bebe Stores (NASDAQ: BEBE) was upgraded to Overweight from Equal Weight at Stephens.
• Cheesecake Factory (NASDAQ: CAKE) was upgraded to Neutral from Underweight at Piper Jaffray.
• Ashland (NYSE: ASH) was upgraded to Buy from Hold at KeyBanc.

Continue reading Analyst upgrades, downgrades and initiations: AMD, AXP, ACI, NOK, NRP, SYK, WPCS

Analyst upgrades, downgrades and initiations: AMD, AXP, ACI, NOK, NRP, SYK, WPCS originally appeared on BloggingStocks on Mon, 24 Aug 2009 12:00:00 EST. Please see our terms for use of feeds.

From TheStreet.com Network

• Sun Micro Reportedly Scraps 'Rock' Chip
• Under-the-Radar Tech Stock for Today

Continue reading Cramer on BloggingStocks: Don't fight the Obama phalanx

Cramer on BloggingStocks: Don't fight the Obama phalanx originally appeared on BloggingStocks on Tue, 16 Jun 2009 10:00:00 EST. Please see our terms for use of feeds.

• Banc of America/Merrill upgraded Lincoln National (NYSE: LNC) to Buy from Underperform and raised its target to $17 from $10 citing expectations that the company will "qualify for and accept TARP funding."
  
• Credit Suisse upgraded AU Optronics (NYSE: AUO) to Outperform from Neutral as it believes inventory levels are low end demand is better than expected.
  
• JP Morgan upgraded Shaw Group (NYSE: SGR) to Overweight from Neutral. The firm views the recent pullback in shares as a buying opportunity given the company's attractive nuke position and expected ramp in government spending.
• Patterson-UTI Energy (NASDAQ: PTEN) was upgraded to Buy from Neutral at Goldman.
  
• Barrick Gold (NYSE: ABX) was raised to Overweight from Market Weight at Thomas Weisel.
  
• Stryker (NYSE: SYK) was lifted to Sector Perform from Underperform at RBC Capital.

Continue reading Analyst upgrades, downgrades and initiations: LNC, AZN, APOL, PNRA ...

Analyst upgrades, downgrades and initiations: LNC, AZN, APOL, PNRA ... originally appeared on BloggingStocks on Tue, 21 Apr 2009 10:40:00 EST. Please see our terms for use of feeds.

Continue reading Stryker (SYK) bone-growth putty fails regulatory challenge

Stryker (SYK) bone-growth putty fails regulatory challenge originally appeared on BloggingStocks on Wed, 01 Apr 2009 13:30:00 EST. Please see our terms for use of feeds.

Continue reading Stock pick and pans for troubled times: TIVO, MCD, BAA, SJM, AVP, SYK, CL ...

Stock pick and pans for troubled times: TIVO, MCD, BAA, SJM, AVP, SYK, CL ... originally appeared on BloggingStocks on Fri, 30 Jan 2009 18:30:00 EST. Please see our terms for use of feeds.

"Stryker (NYSE: SYK) is a bargain at 15.1x next 12-month EPS," says J. Royden Ward, editor of The Cabot Benjamin Graham Value Letter, a service which focuses on stocks that would be well-suited to the investing strategy of Ben Graham, legendary value investor and mentor to Warren Buffett.

"Stryker develops, manufactures and sells specialty surgical and medical products. Its orthopedic division makes hip, knee and other implants.

"SYK also makes a wide variety of medical products and instruments ranging from hospital beds to medical video cameras, surgical drills and saws, and instruments for implants.

Continue reading Stryker (SYK): 'Hip' choice in surgical products

Stryker (SYK): 'Hip' choice in surgical products originally appeared on BloggingStocks on Thu, 29 Jan 2009 14:00:00 EST. Please see our terms for use of feeds.

Medtronic (NYSE: MDT) closed at $39.93. MDT is scheduled to report Q2 EPS on November 18. MDT November 40 straddle is priced at $3.50, December 40 is at $5.50. MDT December option implied volatility of 54 is above its 26-week average of 32 according to Track Data, suggesting larger price movement.

Covidien (NYSE: COV), a medical solutions device provider, closed at $37.07. COV is scheduled to report Q4 EPS on November 17. COV November 40 straddle is priced at $4.40, December 40 straddle is priced at $6.40. COV December option implied volatility of 58 is above its 26-week average of 32 according to Track Data, suggesting larger price movement.

Abbott Lab (NYSE: ABT) closed at $57.14. ABT December option implied volatility of 42 is above its 26-week average of 32 according to Track Data, suggesting larger price movement.

Stryker (NYSE: SYK), a medical technology company, closed at $47.70. SYK December option implied volatility of 60 is above its 26-week average of 32 according to Track Data, suggesting larger price movement.

Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com

Options Update: Medical solution providers volatility increases; MDT, COV, ABT, SYK originally appeared on BloggingStocks on Fri, 14 Nov 2008 10:00:00 EST. Please see our terms for use of feeds.

MOST NOTEWORTHY:

• Baird upgraded shares of Stryker (NYSE: SYK) to Outperform from Neutral as they believe the company's manufacturing problems are more manageable than expected and that supply constraints involving the Trident acetabular cup appear more limited.
  
• Wachovia raised General Dynamics (NYSE: GD) to Outperform from Market Perform, citing valuation, likely resumption in buybacks, and conservative guidance.
  
• Oppenheimer upgraded shares of Garmin (NASDAQ: GRMN) to Outperform from Perform on valuation, as they believe sentiment has troughed and that downward revisions are already priced into shares.

• Merrill raised Turkcell (NYSE: TKC) to Buy from Neutral.
  
• Lehman upgraded HealthSouth (NYSE: HLS) to Overweight from Underweight.
  
• Bear Stearns upgraded McAfee (NYSE: MFE) to Outperform from Peer Perform.

Analyst upgrades: Stryker, General Dynamics, Garmin originally appeared on BloggingStocks on Thu, 24 Jan 2008 12:22:00 EST. Please see our terms for use of feeds.

Stryker (SYK) is hardly striking out originally appeared on BloggingStocks on Wed, 26 Dec 2007 10:15:00 EST. Please see our terms for use of feeds.

General Electric (NYSE: GE) will report third quarter EPS on 10/12.

• Alex Brown says: "Given attractive risk/reward verses our $47 TP, we reiterate Buy."
  
• Investors and analysts have frequently called for the sale of NBC Universal because of its declining revenue and GE's 'Six Sigma' discipline not being compatible with Hollywood sensibilities.
  
• GE October option implied volatility of 24 is above its 26-week average of 20 according to Track Data, suggesting larger risk.

Stryker (NYSE: SYK), a medical technology company with a broad range of products in orthopedics and medical specialties, closed $73.14.

• SYK will report EPS on 10/17.
  
• SYK has been frequently subject to unconfirmed buyout chatter.
  
• SYK October option implied volatility of 34 is above its 26-week average of 25 according to Track Data, suggesting larger price fluctuations.

Daily options Update is provided by Stock Specialist Paul Foster of theflyonthewall.com.

Option update: GE implied volatility up into EPS originally appeared on BloggingStocks on Mon, 08 Oct 2007 09:45:00 EST. Please see our terms for use of feeds.

Apple (NASDAQ: AAPL) volatility elevated at 42 into iPhone. AAPL's iPhone will be in stores on Friday June 29th. Thomas Weisel says: "Checks suggest Macs are strong; iPhone in, just as iPod seems to be peaking; raising estimates." AAPL is expected to report earnings in late July. AAPL July and August option implied volatility of 42 is above its 26-week average of 35 according to Track Data, suggesting larger risk.

Stryker (NYSE: SYK) implied volatility at elevated into 7/19 earnings and guidance. SYK, a medical technology company with a broad range of products in orthopedics and medical specialties, will report earnings on 7/19. Goldman Sachs CO says: "we are removing SYK from the Americas Investment Buy list. There is no change to our constructive stance on SYK, as the outlook for volume/pricing trends and free cash flow generation remains solid." SYK July option implied volatility of 24 is above its 26-week average of 21 according to Track Data, suggesting larger price fluctuations.

Option volume leaders today are: Dendreon (NASDAQ: DNDN) and General Motors (NYSE: GM).

Daily Option Update is provided by Stock Options Specialist Paul Foster of theflyonthewall.com.

Option update 6-28-07: Apple volatility elevated into iPhone originally appeared on BloggingStocks on Thu, 28 Jun 2007 13:35:00 EST. Please see our terms for use of feeds.

Smith & Nephew plc (NYSE:SNN) announced the acquisition this morning of Swiss company Plus Orthopedics for $889 million in cash. This will solidify Smith & Nephew's position as the number 4 global player. The other three major firms are Stryker Corp. (NYSE:SYK), Zimmer Holdings (NYSE:ZMH), and soon to be acquired Biomet Inc. (NASDAQ:BMET). Biomet is undergoing due diligence by a group of private equity firms led by the Blackstone Group. The transaction is expected to close by October of this year.

The orthopedic sector has the wind at its back. The approval process for an orthopedic device is rigorous, but not as lengthy as the cardiac device sector. The marketplace is global in nature and the demographics are about to enter the sweet spot.

With 78 million U.S. baby boomers alone, and another 80 million-plus baby boomers in the European markets, the aging of this group is ripe for the sector. New hips, knees, elbows and shoulders will see record recipients as each year unfolds. Besides the basic joint-replacement products, the spinal sector is also expected to see massive growth. Minimally invasive surgical procedures are expanding the addressable market as the risk profile for such surgeries is significantly less. The dread of osteoporosis affects nearly 700,000 women in the United States alone.

Continue reading Orthopedic sector -- global and consolidating

Orthopedic sector -- global and consolidating originally appeared on BloggingStocks on Mon, 12 Mar 2007 14:00:00 EST. Please see our terms for use of feeds.